Flextract
Payments companies reported to CMS as associated with Flextract. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Flextract, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Flextract
These are the largest totals companies reported as associated with Flextract. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Fieno | Alabaster, AL | Cardiovascular Disease | $4,909.00 |
| Sunil Kapur | Boston, MA | Cardiovascular Disease | $3,771.25 |
| Eugene Fu | Columbus, OH | Clinical Cardiac Electrophysiology | $3,315.86 |
| Joseph Muhlestein | Billings, MT | Clinical Cardiac Electrophysiology | $3,061.44 |
| Gabriel Soto | Saint Louis, MO | Clinical Cardiac Electrophysiology | $2,139.75 |
Prescribed Flextract?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.